Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04850846 |
|
Recruitment Status :
Recruiting
First Posted : April 20, 2021
Last Update Posted : August 15, 2023
|
Sponsor:
Dana-Farber Cancer Institute
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Omar Nadeem, MD, Dana-Farber Cancer Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 31, 2024 |
| Estimated Study Completion Date : | January 31, 2025 |